Literature DB >> 17176683

Survey of medication therapy management programs under Medicare part D.

Daniel R Touchette1, Anne L Burns, Marcie A Bough, Juan C Blackburn.   

Abstract

OBJECTIVE: To describe and summarize the enrollment criteria and benefit designs for medication therapy management (MTM) programs offered throughout the United States during the first year of the Medicare Part D benefit.
DESIGN: Cross-sectional survey.
SETTING: United States between November 1, 2005, and June 30, 2006. PARTICIPANTS: MTM benefit plan managers of major health insurance companies nationwide selected nonrandomly by the investigators from lists provided by the Centers for Medicare & Medicaid Services. INTERVENTION: Telephone interview and/or e-mail 12-item survey with mostly open-ended questions. MAIN OUTCOME MEASURES: Characteristics required for a patient to be enrolled in MTM programs and types of services provided along with modes of delivery.
RESULTS: Interviews were completed or surveys returned from 21 distinct MTM programs representing 70 health insurance plans covering 12.1 million Medicare enrollees. Of the MTM programs offered, 90.5% restricted their enrollment based on number of diseases, with a median of 3 (range, 2-5) diseases required; 57.1% restricted enrollment based on the type of chronic condition; and 95.2% had requirements for the number of medications (median, 6; range, 2-24) necessary for enrollment in the program. The most frequently provided MTM services were patient education (75.0% of programs),patient adherence (70.0%), and medication review (60.0%). The median number of different service types provided by MTM programs was 3 (range, 2-7). MTM program services included the use of mailed interventions (76.1%) and inhouse call centers (90.4%). While only 4 of the 21 MTM programscontracted with pharmacies to provide some or all of their MTM services, these plans covered a large number of beneficiaries (7.5 million lives).
CONCLUSION: MTM programs offered by prescription drug plans and Medicare Advantage plans were highly variable during the first year of the Medicare Part D benefit. Definitive evidence supporting the effectiveness of many of the most common interventions is lacking.

Entities:  

Mesh:

Year:  2006        PMID: 17176683     DOI: 10.1331/1544-3191.46.6.683.touchette

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  6 in total

1.  Pharmacy students' knowledge of the Medicare drug benefit and intention to provide Medicare medication therapy management services.

Authors:  Julie M Urmie; Karen B Farris; Kathleen E Herbert
Journal:  Am J Pharm Educ       Date:  2007-06-15       Impact factor: 2.047

Review 2.  Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services.

Authors:  Sherilyn K D Houle; Kelly A Grindrod; Trish Chatterley; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2014-07

Review 3.  Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.

Authors:  Elisabeth Lilian Pia Sattler; Jung Sun Lee; Matthew Perri
Journal:  Drugs Aging       Date:  2013-06       Impact factor: 3.923

4.  Elective course on medication therapy management services.

Authors:  Catherine Kuhn; Patricia H Powell; James J Sterrett
Journal:  Am J Pharm Educ       Date:  2010-04-12       Impact factor: 2.047

5.  Pharmacists' knowledge and attitudes toward medication therapy management service and the associated challenges and barriers for its implementation.

Authors:  Anan S Jarab; Walid Al-Qerem; Tareq L Mukattash; Shorouq R Abuhishmah; Sojoud Alkhdour
Journal:  Saudi Pharm J       Date:  2022-03-14       Impact factor: 4.562

Review 6.  Medication therapy management services: definitions and outcomes.

Authors:  Annette N Pellegrino; Michelle T Martin; Jessica J Tilton; Daniel R Touchette
Journal:  Drugs       Date:  2009       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.